Search results
Results from the WOW.Com Content Network
It was made available for free at the National Library of Medicine's Virtual Asthma Exhibit. [10] In November 2002, the developers received a grant from the Centers for Disease Control and Prevention's (CDC) adolescent and school health program, allowing them to distribute the game to school nurses at more than 30,000 elementary, middle and ...
Asthma phenotyping and endotyping has emerged as a novel approach to asthma classification inspired by precision medicine which separates the clinical presentations of asthma, or asthma phenotypes, from their underlying causes, or asthma endotypes. The best-supported endotypic distinction is the type 2-high/type 2-low distinction.
Severe asthma attack can cause symptoms such as: [7] Shortness of breath; Inability to speak in full sentences; Feeling breathless even when lying down; Chest feels tight; Bluish tint to the lips; Hunched shoulders, and strained muscles in stomach and neck; Feeling the need to sit or stand up to breathe more easily
Aspirin-exacerbated respiratory disease (AERD), also called NSAID-exacerbated respiratory disease (N-ERD) or historically aspirin-induced asthma and Samter's Triad, is a long-term disease defined by three simultaneous symptoms: asthma, chronic rhinosinusitis with nasal polyps, and intolerance of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs).
An anti-asthmatic agent, also known as an anti-asthma drug, refers to a drug that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies ...
The mechanisms behind allergic asthma—i.e., asthma resulting from an immune response to inhaled allergens—are the best understood of the causal factors. In both people with asthma and people who are free of the disease, inhaled allergens that find their way to the inner airways are ingested by a type of cell known as antigen-presenting ...
Rates of asthma rates in 2017 [1] As of 2011, approximately 235 million people worldwide were affected by asthma, [2] and roughly 250,000 people die per year from asthma-related causes. [3] Low and middle income countries make up more than 80% of the mortality. [4] Prevalences vary between countries from 1% to 18%. [3]
GINA conducts continuous review of scientific publications on asthma and is a leader in disseminating information about the care of patients with asthma. [2] GINA publishes resources such as evidence-based guidelines for asthma management, and runs special events such as World Asthma Day. GINA's guidelines, revised each year, are used by ...